Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism

César Rodriguez-Gonzalez, Julio; Hernández, Ivones; Declerck, Ken; Pérez-Novo, Claudina; Logie, Emilie; Theys, Claudia; Jakubek, Patrycja; Luisa Quiñones-Maza, Olga; Dantas-Cassali, Geovanni; Carlos dos Reis, Diego; Van Camp, Guy; Teresa Lopes Paz, Miriam; Rodeiro-Guerra, Idania; Delgado, René; Vanden Berghe, Wim

doi:10.3389/fphar.2021.670167

Public

Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism

Published in Frontiers in Pharmacology • Dec 3, 2021

Authors:

Julio César Rodriguez-Gonzalez

Ivones Hernández

Ken Declerck

Abstract

In spite of the current advances and achievements in cancer treatments, colorectal cancer (CRC) persists as one of the most prevalent and deadly tumor types in both men and women worldwide. Drug resistance, adverse side effects and high rate of angiogenesis, metastasis and tumor relapse remain one o...

Subject

Cancer research

Colorectal cancer

Metastasis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!